78 related articles for article (PubMed ID: 17572515)
21. Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics.
Sini P; Samarzija I; Baffert F; Littlewood-Evans A; Schnell C; Theuer A; Christian S; Boos A; Hess-Stumpp H; Foekens JA; Setyono-Han B; Wood J; Hynes NE
Cancer Res; 2008 Mar; 68(5):1581-92. PubMed ID: 18316624
[TBL] [Abstract][Full Text] [Related]
22. Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors.
Mukherjee P; Abate LE; Seyfried TN
Clin Cancer Res; 2004 Aug; 10(16):5622-9. PubMed ID: 15328205
[TBL] [Abstract][Full Text] [Related]
23. Antiangiogenic therapy: creating a unique "window" of opportunity.
Lin MI; Sessa WC
Cancer Cell; 2004 Dec; 6(6):529-31. PubMed ID: 15607955
[TBL] [Abstract][Full Text] [Related]
24. [Transplantation and magnetic resonance imaging of transplantable human glioma tissue in the brain of nude mice].
Li RJ; Diao Y; Huang Q; Shen JK; Lan Q
Ai Zheng; 2007 Sep; 26(9):937-41. PubMed ID: 17927848
[TBL] [Abstract][Full Text] [Related]
25. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
26. Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.
Marini P; Budach W; Niyazi M; Junginger D; Stickl S; Jendrossek V; Belka C
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):198-202. PubMed ID: 19695436
[TBL] [Abstract][Full Text] [Related]
27. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM
Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975
[TBL] [Abstract][Full Text] [Related]
28. VEGF-dependent induction of CD62E on endothelial cells mediates glioma tropism of adult haematopoietic progenitor cells.
Tabatabai G; Herrmann C; von Kürthy G; Mittelbronn M; Grau S; Frank B; Möhle R; Weller M; Wick W
Brain; 2008 Oct; 131(Pt 10):2579-95. PubMed ID: 18689869
[TBL] [Abstract][Full Text] [Related]
29. Phenyl-tert-butylnitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model.
Doblas S; Saunders D; Kshirsagar P; Pye Q; Oblander J; Gordon B; Kosanke S; Floyd RA; Towner RA
Free Radic Biol Med; 2008 Jan; 44(1):63-72. PubMed ID: 18045548
[TBL] [Abstract][Full Text] [Related]
30. Targeting of the receptor protein tyrosine phosphatase beta with a monoclonal antibody delays tumor growth in a glioblastoma model.
Foehr ED; Lorente G; Kuo J; Ram R; Nikolich K; Urfer R
Cancer Res; 2006 Feb; 66(4):2271-8. PubMed ID: 16489031
[TBL] [Abstract][Full Text] [Related]
31. An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody.
Shen J; Vil MD; Zhang H; Tonra JR; Rong LL; Damoci C; Prewett M; Deevi DS; Kearney J; Surguladze D; Jimenez X; Iacolina M; Bassi R; Zhou K; Balderes P; Mangalampalli VR; Loizos N; Ludwig DL; Zhu Z
Biochem Biophys Res Commun; 2007 Jun; 357(4):1142-7. PubMed ID: 17462601
[TBL] [Abstract][Full Text] [Related]
32. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
Zhang T; Guan M; Xu C; Chen Y; Lu Y
Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663
[TBL] [Abstract][Full Text] [Related]
33. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
34. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth.
deCarvalho AC; Zhang X; Roberts C; Jiang F; Kalkanis SN; Hong X; Lu M; Chopp M
Glia; 2007 Aug; 55(10):1053-60. PubMed ID: 17551928
[TBL] [Abstract][Full Text] [Related]
35. Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors.
Bello L; Giussani C; Carrabba G; Pluderi M; Lucini V; Pannacci M; Caronzolo D; Tomei G; Villani R; Scaglione F; Carroll RS; Bikfalvi A
Clin Cancer Res; 2002 Nov; 8(11):3539-48. PubMed ID: 12429645
[TBL] [Abstract][Full Text] [Related]
36. [Experimental study on immunotherapy of meningeal gliomatosis with monoclonal antibody].
Yamashita Y; Takahashi H; Nakazawa S
No To Shinkei; 1993 Jan; 45(1):63-70. PubMed ID: 8476656
[TBL] [Abstract][Full Text] [Related]
37. A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites.
Bernsen HJ; Rijken PF; Hagemeier NE; van der Kogel AJ
Microvasc Res; 1999 May; 57(3):244-57. PubMed ID: 10329251
[TBL] [Abstract][Full Text] [Related]
38. Antitumor treatment efficacy by targeting epidermal growth factor receptor and vascular endothelial growth factor receptor-2 in an orthotopic human glioblastoma model.
Yi D; Hua TX; Lin HY; Kui CL; Ning LX; Wang ZZ
J Neurooncol; 2011 Aug; 104(1):93-101. PubMed ID: 21140283
[TBL] [Abstract][Full Text] [Related]
39. Detecting vascular changes in tumour xenografts using micro-ultrasound and micro-ct following treatment with VEGFR-2 blocking antibodies.
Cheung AM; Brown AS; Cucevic V; Roy M; Needles A; Yang V; Hicklin DJ; Kerbel RS; Foster FS
Ultrasound Med Biol; 2007 Aug; 33(8):1259-68. PubMed ID: 17467156
[TBL] [Abstract][Full Text] [Related]
40. Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus model.
Watanabe H; Mamelak AJ; Weiss E; Wang B; Freed I; Brice AK; Wachtman L; Gabrielson KL; Yokota N; Hicklin DJ; Kerbel RS; Haas M; Sauder DN
Clin Cancer Res; 2005 Jan; 11(1):407-9. PubMed ID: 15671573
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
